The supplement industry is undergoing a significant shift in focus, with regulatory risk taking center stage. This article delves into the recent ACI-CRN forum, where industry experts gathered to navigate the complex and ever-changing landscape of dietary supplement regulations.
Regulatory Landscape: A Complex Web
The forum, attended by lawyers, regulators, and industry stakeholders, highlighted the challenges posed by an uncertain regulatory environment. Megan Olsen, from the Council for Responsible Nutrition, set the tone, acknowledging the rapid pace of change and the need to adapt.
"The challenges are major, and they're not going away," she said.
This sentiment was echoed throughout the event, with a particular focus on the U.S. Food and Drug Administration's (FDA) Office of Dietary Supplement Programs (ODSP) and its strategic priorities. Cara Welch, the director of ODSP, emphasized the need to modernize dietary supplement oversight, a key aspect of the MAHA agenda.
Modernizing Oversight: The MAHA Agenda
The MAHA agenda, a driving force in the industry, aims to eliminate the Generally Recognized as Safe (GRAS) loophole and implement new dietary ingredient (NDI) guidance. This agenda is a response to the evolving nature of dietary substances and the need to reconcile scientific advancements with legal definitions.
"It's a delicate balance between innovation and regulation," Dr. Welch noted.
The FDA is currently reviewing comments on this matter, with a focus on how dietary ingredients enter the market and the interpretation of the dietary substance clause. This review process is expected to influence the final NDI guidance, which is anticipated by the end of the year.
Risk Management: Adapting to Uncertainty
With rapid policy shifts and an uncertain operating environment, businesses are reevaluating their risk management strategies. A panel discussion titled "When Business as Usual No Longer Applies" highlighted the need for companies to adapt to constant change and manage uncertainty.
Tara Martin, from Jamieson Wellness, emphasized the challenge of navigating an environment with a lack of clarity and a rapid pace of change. Jeff Brams, from LMNT, offered a brand perspective, focusing on ingredient sourcing and consumer satisfaction rather than getting distracted by the "squirrels" of regulatory changes.
"We can't let fear drive our decisions," Martin added.
The consensus was that while volatility increases risk, it also presents opportunities for innovation. Companies are encouraged to adopt a more agile approach, incorporating early-stage risk assessment, supplier coordination, and a consumer-centric mindset.
Key Takeaways: A Roadmap for Adaptation
The forum provided several key takeaways for businesses looking to navigate the regulatory landscape:
- Early Review: Build regulatory, legal, and quality reviews into the innovation process from the start.
- Supplier Collaboration: Strengthen engagement with suppliers to ensure a clear understanding of ingredient status, safety, and potential regulatory pathways.
- Document Decisions: Maintain a written record to explain and defend product, ingredient, and claims decisions.
- Monitor Beyond Federal Agencies: Track a range of sources, including social media, to stay ahead of emerging issues.
- Utilize Technology: Leverage AI-enabled tools for efficient risk monitoring.
- Functional Food Caution: Carefully assess functional food products and their claims.
- Flexibility is Key: Prepare to adapt quickly to changing guidance and enforcement priorities.
- Focus on Consumers: Prioritize clear communication, product quality, and consumer trust.
In conclusion, the supplement industry is facing a period of intense regulatory scrutiny and change. By adapting their strategies and staying informed, businesses can navigate these challenges and capitalize on the opportunities that arise.
